Tivic Health Systems, Inc. (TIVC)
USD 4.73
(-2.85%)
USD 4.73
(-2.85%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.17 Million USD | -36.09% |
| 2022 | 1.84 Million USD | 57.8% |
| 2021 | 1.16 Million USD | 35.58% |
| 2020 | 860 Thousand USD | 104.76% |
| 2019 | 420 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 334 Thousand USD | -6.44% |
| 2024 Q2 | 140 Thousand USD | -58.08% |
| 2023 Q2 | 161 Thousand USD | -57.18% |
| 2023 Q1 | 376 Thousand USD | -7.84% |
| 2023 FY | 1.17 Million USD | -36.09% |
| 2023 Q4 | 357 Thousand USD | 26.6% |
| 2023 Q3 | 282 Thousand USD | 75.16% |
| 2022 Q4 | 408 Thousand USD | -14.47% |
| 2022 Q2 | 528 Thousand USD | 23.36% |
| 2022 Q1 | 428 Thousand USD | 16.94% |
| 2022 FY | 1.84 Million USD | 57.8% |
| 2022 Q3 | 477 Thousand USD | -9.66% |
| 2021 Q3 | 277 Thousand USD | 3.36% |
| 2021 Q4 | 366 Thousand USD | 32.13% |
| 2021 Q2 | 268 Thousand USD | -17.03% |
| 2021 FY | 1.16 Million USD | 35.58% |
| 2021 Q1 | 323 Thousand USD | -12.94% |
| 2020 Q3 | 243 Thousand USD | 95.97% |
| 2020 FY | 860 Thousand USD | 104.76% |
| 2020 Q4 | 371 Thousand USD | 52.67% |
| 2020 Q2 | 124 Thousand USD | 1.64% |
| 2020 Q1 | 122 Thousand USD | 0.0% |
| 2019 FY | 420 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 90.248% |
| BrainsWay Ltd. | 31.78 Million USD | 96.3% |
| Cerus Corporation | 156.36 Million USD | 99.248% |
| Envoy Medical, Inc. | 316 Thousand USD | -272.152% |
| electroCore, Inc. | 16.03 Million USD | 92.664% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -82.609% |
| IceCure Medical Ltd | 3.22 Million USD | 63.58% |
| Inogen, Inc. | 315.66 Million USD | 99.627% |
| OrthoPediatrics Corp. | 148.73 Million USD | 99.209% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 51.565% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -222.193% |
| MaxCyte, Inc. | 41.28 Million USD | 97.152% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | 39.768% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -961.87% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.842% |
| PAVmed Inc | 2.45 Million USD | 52.039% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 94.778% |
| RxSight, Inc. | 89.07 Million USD | 98.68% |
| Sight Sciences, Inc. | 81.05 Million USD | 98.549% |
| SI-BONE, Inc. | 138.88 Million USD | 99.153% |
| TELA Bio, Inc. | 58.45 Million USD | 97.988% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 99.372% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 91.479% |
| Acutus Medical, Inc. | 7.16 Million USD | 83.585% |
| Talis Biomedical Corporation | 412 Thousand USD | -185.437% |
| Spectral AI, Inc. | 18.05 Million USD | 93.487% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 88.127% |
| CVRx, Inc. | 39.29 Million USD | 97.007% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -21.399% |
| Bioventus Inc. | 512.34 Million USD | 99.77% |
| Venus Concept Inc. | 76.35 Million USD | 98.46% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 93.647% |
| LivaNova PLC | 1.15 Billion USD | 99.898% |
| 908 Devices Inc. | 50.22 Million USD | 97.659% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.756% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -1426.4% |
| NeuroPace, Inc. | 65.42 Million USD | 98.202% |
| LENSAR, Inc. | 42.16 Million USD | 97.211% |
| Apyx Medical Corporation | 52.34 Million USD | 97.754% |
| Cutera, Inc. | 212.36 Million USD | 99.446% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 96.475% |
| BioSig Technologies, Inc. | 18 Thousand USD | -6433.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 99.294% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 95.091% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.924% |
| Axonics, Inc. | 366.37 Million USD | 99.679% |
| Outset Medical, Inc. | 130.37 Million USD | 99.098% |
| IRIDEX Corporation | 51.86 Million USD | 97.733% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 99.137% |
| IRadimed Corporation | 65.56 Million USD | 98.206% |
| INVO Bioscience, Inc. | 3.02 Million USD | 61.067% |
| Telesis Bio, Inc. | 27.5 Million USD | 95.725% |
| Viemed Healthcare, Inc. | 183 Million USD | 99.357% |
| Varex Imaging Corporation | 811 Million USD | 99.855% |
| Quipt Home Medical Corp. | 221.74 Million USD | 99.47% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 98.288% |
| Dynatronics Corporation | 32.53 Million USD | 96.385% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 86.448% |
| Semler Scientific, Inc. | 68.18 Million USD | 98.275% |
| InMode Ltd. | 492.04 Million USD | 99.761% |
| Bruker Corporation | 2.96 Billion USD | 99.96% |
| Cytosorbents Corporation | 36.34 Million USD | 96.765% |
| DexCom, Inc. | 3.62 Billion USD | 99.968% |
| Align Technology, Inc. | 3.86 Billion USD | 99.97% |
| Viveve Medical, Inc. | 6.42 Million USD | 81.699% |
| ZimVie Inc. | 457.43 Million USD | 99.743% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 99.391% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -961.87% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.843% |
| Profound Medical Corp. | 7.33 Million USD | 83.959% |
| Insulet Corporation | 1.69 Billion USD | 99.931% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 99.067% |
| iCAD, Inc. | 17.31 Million USD | 93.209% |
| Nuwellis, Inc. | 8.86 Million USD | 86.733% |
| Biotricity, Inc. | 12.06 Million USD | 90.251% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.761% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 81.048% |
| PAVmed Inc. | 2.45 Million USD | 52.039% |
| BIOLASE, Inc. | 49.16 Million USD | 97.608% |
| Beyond Air, Inc. | 1.15 Million USD | -1.467% |
| FONAR Corporation | 102.88 Million USD | 98.857% |
| AxoGen, Inc. | 159.01 Million USD | 99.26% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.571% |
| Inari Medical, Inc. | 493.63 Million USD | 99.762% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.706% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -6222.581% |
| Tenon Medical, Inc. | 2.92 Million USD | 59.836% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 82.736% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.963% |
| Sintx Technologies, Inc. | 2.62 Million USD | 55.234% |
| NanoVibronix, Inc. | 2.28 Million USD | 48.489% |
| Quanterix Corporation | 122.36 Million USD | 99.039% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 95.181% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.414% |
| TransMedics Group, Inc. | 241.62 Million USD | 99.513% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 91.511% |
| NeuroMetrix, Inc. | 5.9 Million USD | 80.073% |
| Hyperfine, Inc. | 11.03 Million USD | 89.34% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 99.288% |
| Biomerica, Inc. | 5.41 Million USD | 78.283% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 97.674% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 99.336% |